Effects of intermittent hypobaric hypoxia on blood lipid concentrations in male coronary heart disease patients.

@article{Tinkov2002EffectsOI,
  title={Effects of intermittent hypobaric hypoxia on blood lipid concentrations in male coronary heart disease patients.},
  author={A N Tin'kov and V. A. Aksenov},
  journal={High altitude medicine \& biology},
  year={2002},
  volume={3 3},
  pages={
          277-82
        }
}
The objective of the study was to evaluate the effects of intermittent hypobaric hypoxia (IHH) on plasma lipid concentrations of male coronary heart disease (CHD) patients. Forty-six male coronary patients were enrolled in the study. Thirty had a history of myocardial infarction and 16 had ischemic episodes documented by ergometer testing or Holter monitoring. The patients underwent acclimation to hypoxia by means of a protocol of intermittent exposure in a hypobaric chamber. Lipid profiles… 
View on PubMed
go2altitude.com
45 Citations
Highly Influential Citations
3
Background Citations
18
Methods Citations
3
Results Citations
3

Figures and Tables from this paper

45 Citations

Chronic intermittent hypoxia at high altitude exposure for over 12 years: assessment of hematological, cardiovascular, and renal effects.

In chronic intermittent hypoxia exposure even over longer periods, most subjects still show symptoms of acute altitude illnesses, but a faster recovery.

Effects of a Single Bout of Interval Hypoxia on Cardiorespiratory Control in Patients With Type 1 Diabetes

Interval hypoxia (IH) was successfully used to improve the adaptation to Hypoxia in patients with chronic obstructive pulmonary disease and induced an initial adaptation to hypoxIA, with improvement in respiratory reflexes.

Intermittent hypoxia training as non-pharmacologic therapy for cardiovascular diseases: Practical analysis on methods and equipment

A bright future is envisaged for IHT to play a more significant role in the preventive and complementary medicine against cardiovascular diseases.

Depressive Effects of Chronic Intermittent Hypobaric Hypoxia on Renal Vascular Hypertension through Enhancing Baroreflex.

The data suggest that CIHH treatment produces an anti-hypertensive effect in RVH rats, likely due to facilitating baroreflex function, and represents a novel potential therapeutics to treat hypertension.

Exposure to Normobaric Hypoxia Combined with a Mixed Diet Contributes to Improvement in Lipid Profile in Trained Cyclists

Hypoxic conditions combined with a mixed diet with a controlled mixed diet can induce beneficial changes in lipid profile even in highly trained athletes.

Health effects of intermittent hypoxic exposure in a sedentary population

Overall, IHE appears to increase the parasympathetic contribution to the sympathovagal balance of the heart at rest in a sedentary, middle-aged population.

Does intermittent hypoxic exposure enhance the cardioprotective effect of exercise in an inactive population?

The conflicting findings indicate that in inactive adults, the addition of IHE to exercise may be beneficial to systemic markers of cardiovascular health but may also increase myocardial load due to increased arterial wave reflection.

Effects of interval hypoxia on exercise tolerance: special focus on patients with CAD or COPD

Benefits on exercise tolerance seem to be greater in patients with CAD or COPD when compared to healthy subjects, and interval hypoxia might become an attractive strategy to complement the known beneficial effects of exercise training.

Effects of a Single Bout of Interval Hypoxia on Cardiorespiratory Control and Blood Glucose in Patients With Type 2 Diabetes

A single bout of IH induced an initial adaptation to hypoxia, with improvement in cardiorespiratory reflexes and reduction in blood glucose, and patients with type 2 diabetes could potentially benefit from the application of a full (>2 weeks) IH intervention.

Effects of intermittent hypoxia on the heart.

In a mouse model of OSA, it is found that IH causes time-dependent alterations of the susceptibility of the heart to oxidative stress, and exposure to prolonged IH allowed reversal of the enhancement of myocardial damage.

References

SHOWING 1-10 OF 32 REFERENCES

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.

[Experience with the risk factor-based prevention of ischemic heart disease at a Pyatigorsk health resort].

: Methods and efficacy of correction of kinesitherapy, body mass and cholesterolemia in CHD prevention were studied in 162 patients with pathology of the locomotor system combined with obesity in the…

[The effect of climatic treatment in the central highlands on the lipid, cortisol, renin and aldosterone content of the blood in patients with an acute myocardial infarct].

It was found that posthospital rehabilitation under conditions of low-mountain climate promoted antiatherogenic shifts in blood lipoproteins composition most distinct in patients with hyperlipidemias, which makes nonpharmacological rehabilitation and secondary prevention of coronary heart disease in low-Mountain climate promising.

[The effect of climatic treatment in the central highlands on the lipid, cortisol, renin and aldosterone content of the blood in patients with an acute myocardial infarct].

It was found that posthospital rehabilitation under conditions of low-mountain climate promoted antiatherogenic shifts in blood lipoproteins composition most distinct in patients with hyperlipidemias, which makes nonpharmacological rehabilitation and secondary prevention of coronary heart disease in low-Mountain climate promising.

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Results are in accord with two previous trials with different pharmacologic agents and indicate that modification of lipoprotein levels with gemfibrozil reduces the incidence of coronary heart disease in men with dyslipidemia.

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Pravastatin therapy reduced mortality from coronary heart disease and overall mortality, as compared with the rates in the placebo group, as well as the incidence of all prespecified cardiovascular events in patients with a history of myocardial infarction or unstable angina who had a broad range of initial cholesterol levels.

The risk factors for ischemic heart disease in Tibetan highlanders.

Tibetans showed a decreased level of palmitic acid and an increased level of linoleic acid in serum PL which may protect against atherosclerosis, and positive risk factors are likely counteracted by other negative risk factors.

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

It is demonstrated that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels and was also greater in patients with higher pretreatment levels of LDL cholesterol.

[Prevention of atherogenic dislipoproteinemias and metabolic disorders in the liver in emotional-pain stress].

Preadaptation of the animals to moderate hypoxia as well as administration of an antioxidant ionol prevented the activation of lipid peroxidation in liver tissue, liberation of fructose I-phosphate aldolase into blood, depression of 7 alpha-cholesterol hydroxylase and protected against the stress-dependent atherogenous dislipoproteinemia.